Pharvaris Pharma (PHVS) - Bozor bahosi
Noyob kasalliklar sektoriga kirish to'siqlari uzoq muddatli sinovlar va ulkan xarajatlar bilan bog'liq, biroq orfan dori statusi bozor eksklyuzivligini kafolatlaydi. Pharvaris N.V. (PHVS) tor bemorlar guruhini nishonga olgan holda, HAE davolash uchun ilk oral preparatni ishlab chiqmoqda. Innovatsiyalarga bo'lgan barqaror talab kompaniyani inqirozlardan mustaqil bo'lgan defensiv aktivga aylantiradi. Quyida vizuallashtirilgan joriy birja kotirovkalari bilan tasdiqlanganidek, bozor kapitalizatsiyasi 2.38 miqdoriga yetmoqda.
Pharvaris Pharma (PHVS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati Pharvaris N.V.|PHVS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Pharvaris N.V.|PHVS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Pharvaris Pharma|PHVS - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Pharvaris|Tezkor likvidlik koeffitsiyenti pharvaris.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PHVS - Sof foyda|Kelajakdagi foyda Pharvaris N.V.|PHVS - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Pharvaris Corp|PHVS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Pharvaris Pharma|PHVS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Pharvaris|PHVS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi pharvaris.com|PHVS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Pharvaris N.V.
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning fundamental tahlili:PHVS (Pharvaris)
Irsiy angioedema terapiyasi uchun oral formulalarga bo'lgan yuqori talab o'sib borayotgan bozor sharoitida Pharvaris N.V. (PHVS) kompaniyasining baholanish asosini tashkil etadi. Kompaniyaning bozor kapitalizatsiyasini tahlil qilish orqali investor barcha aksiyalarning umumiy qiymatini baholaydi, bu esa aktivning korreksiyalarga nisbatan bozor barqarorligini belgilaydi va choraklik hisobotlardan qat'i nazar, emitentning biznes modeliga bo'lgan kapital ishonchi darajasini ochib beradi.
Muhim raqobatchilar
Bozor kapitallashuvi ARGX (argenx)|Bozor qiymati BNTX|ABVX: Bozor bahosi|ADMA: Bozor qiymati|Protagonist Therapeutics (PTGX) - Bozor qiymati|IMVT - Bozor kapitallashuvi|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|AbCellera (ABCL) - Bozor qiymati|Bozor bahosi Tourmaline|PGEN (Precigen, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi pharming.com|Bozor bahosi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor qiymati|Bozor kapitallashuvi ZBIO (Zenas Biopharma, Inc.)|Bozor kapitallashuvi Immunome Bio (IMNM)|GOSS - Bozor qiymati|kalvista.com (KALV) - Bozor bahosi|Septerna (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharma|Bozor bahosi SVRA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|JBIO - Bozor qiymati|Bozor bahosi ACRS|KYTX: Bozor kapitallashuvi|tizianalifesciences.com - Bozor qiymati|CABA (Cabaletta Bio) - Bozor kapitallashuvi|Bozor kapitallashuvi Ventyx Biosciences Inc.|Bozor qiymati Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Bozor qiymati|Eledon Pharmaceuticals - Bozor bahosi|agenusbio.com - Bozor qiymati|Climb Bio - Bozor kapitallashuvi|ZURA - Bozor kapitallashuvi|aTyr (ATYR) - Bozor qiymati|Adagene Inc. - Bozor qiymati|IMA (ImageneBio) - Bozor kapitallashuvi|Shattuck Therapeutics (STTK) - Bozor kapitallashuvi|Bozor qiymati Equillium, Inc. (EQ)|Bozor kapitallashuvi connectbiopharm.com|Immunic - Bozor bahosi|Bozor qiymati ATRA|IFRX - Bozor qiymati|XFOR (x4pharma.com) - Bozor kapitallashuvi|ACET (adicetbio.com) - Bozor bahosi|CELU - Bozor kapitallashuvi|Bozor bahosi INMB|Bozor qiymati BRNS|Bozor bahosi KZR (Kezar Life Sciences)|Bozor kapitallashuvi sabbiotherapeutics.com|Bozor qiymati Akari Therapeutics Plc AKTX|ENLV (Enlivex Therapeutics Ltd) - Bozor bahosi|Q32 Bio Corp - Bozor kapitallashuvi|Bozor qiymati GOVX (GeoVax Corp)|EDSA (Edesa Biotech, Inc.) - Bozor bahosi|IBIO (ibioinc.com) - Bozor qiymati|Bozor qiymati Carisma Therapeutics Inc|XTL Biopharmaceuticals Ltd (XTLB) - Bozor kapitallashuvi|Bozor qiymati Bolt Biotherapeutics (BOLT)|HCWB: Bozor bahosi|Bozor kapitallashuvi APVO (Aptevo Therapeutics Inc.)|Bozor qiymati AIM|Aditxt Corp - Bozor kapitallashuvi|GRI - Bozor kapitallashuvi|XORTX (XRTX) - Bozor qiymati|Vyome Therapeutics - Bozor qiymati|Bozor qiymati Revelation Biosciences|Bozor bahosi indaptusrx.com (INDP)|Bozor kapitallashuvi SCNI|Bozor kapitallashuvi calcimedica.com (CALI)|Affimed N.V. - Bozor bahosi|Bozor qiymati ALLK|HOOKIPA - Bozor kapitallashuvi|Bozor kapitallashuvi IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Bozor bahosi Ocean Biomedical Inc|Bozor qiymati TC BioPharm (Holdings) PLC|Bozor bahosi Third Harmonic Bio Inc (THRD)
